Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025

Immunoprobe-based method to assess organ injury status through a biofluid-based cell-free DNA (CFDNA) assay

US Patent 11124824 · Granted Sep 21, 2021

Assignee

Inventors

View full patent text on Google Patents →